- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neuraxis Inc (NRXS)
Neuraxis Inc stock price live, this page displays NYSE NRXS stock exchange data. View the NRXS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neuraxis Inc real time stock price chart below.
What Is the Neuraxis Inc Stock Price Today?
The Neuraxis Inc stock price today is 2.500.
What Is the Stock Symbol for Neuraxis Inc?
The stock symbol for Neuraxis Inc is ""NRXS.""
What Stock Exchange Does Neuraxis Inc Trade On?
Neuraxis Inc is listed and trades on the NYSE stock exchange.
Is Neuraxis Inc a Good Stock to Buy?
Determining whether Neuraxis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRXS quote. (ISIN: US64134X2018)
What Is the Neuraxis Inc Stock Price Today?
The Neuraxis Inc stock price today is 2.500.
What Is the Stock Symbol for Neuraxis Inc?
The stock symbol for Neuraxis Inc is ""NRXS.""
What Stock Exchange Does Neuraxis Inc Trade On?
Neuraxis Inc is listed and trades on the NYSE stock exchange.
Is Neuraxis Inc a Good Stock to Buy?
Determining whether Neuraxis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRXS quote. (ISIN: US64134X2018)
NYSE
Currency in USD
2.500
-0.120(-4.58%)
Closed·
After Hours
2.5000.000(0.00%)
·
Fair Value
An estimate of a Neuraxis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.500
2.620
52 wk Range
1.330
6.200
NRXS Scorecard
Full Analysis
Quickly burning through cash
NRXS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Neuraxis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.5002.620
52 wk Range
1.3306.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NRXS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Neuraxis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.250
Upside
+150.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Neuraxis settles lawsuit with $750,000 agreement
- Investing.com
- Form 8K Neuraxis Inc For: 3 July
- Investing.com
- Form 8K Neuraxis Inc For: 3 July
- Investing.com
- Form 8K Neuraxis Inc For: 22 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Neuraxis Inc Company Profile
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Neuraxis Inc Earnings Call Summary for Q1/2025
- Revenue up 39% to $896,000 in Q1 2025; unit sales increased 46%; operating losses rose 25% to $2.3 million
- Stock surged 11% post-earnings; analysts set $4.75 target price; revenue forecast to grow 1,300% in current fiscal year
- Insurance coverage expanded to 51 million lives; FDA label for IV Stem Technology broadened to include wider age range
- Company aims for cash flow breakeven; anticipates accelerated revenue growth; Category One CPT Code implementation in early 2026
- Guidelines publication expected by end of May; payers estimated to take 90-120 days for policy coverage adoption
Last Updated: 12/05/2025, 14:54
Read Full TranscriptCompare NRXS to Peers and Sector
Metrics to compare | NRXS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNRXSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | −3.8x | −0.5x | |
PEG Ratio | −0.04 | −0.28 | 0.00 | |
Price/Book | 93.7x | 2.5x | 2.6x | |
Price / LTM Sales | 8.1x | 3.7x | 3.3x | |
Upside (Analyst Target) | 150.0% | 20.3% | 45.4% | |
Fair Value Upside | Unlock | 7.8% | 7.7% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.250
(+150.00% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-0.33 / --
Revenue / Forecast
900.00K / --
People Also Watch
FAQ
What Stock Exchange Does Neuraxis Trade On?
Neuraxis is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Neuraxis?
The stock symbol for Neuraxis is "NRXS."
What Is the Neuraxis Market Cap?
As of today, Neuraxis market cap is 23.82M.
What Is Neuraxis's Earnings Per Share (TTM)?
The Neuraxis EPS (TTM) is -1.23.
When Is the Next Neuraxis Earnings Date?
Neuraxis will release its next earnings report on 17 Sept 2025.
From a Technical Analysis Perspective, Is NRXS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Neuraxis Stock Split?
Neuraxis has split 0 times.
How Many Employees Does Neuraxis Have?
Neuraxis has 21 employees.
What is the current trading status of Neuraxis (NRXS)?
As of 03 Aug 2025, Neuraxis (NRXS) is trading at a price of 2.50, with a previous close of 2.62. The stock has fluctuated within a day range of 2.50 to 2.62, while its 52-week range spans from 1.33 to 6.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.